A Relative Bioavailability Study of 60 mg Nifedipine Extended Release Tablets Under Fasting Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-03-19
- Last Posted Date
- 2010-08-17
- Lead Sponsor
- Actavis Inc.
- Target Recruit Count
- 96
- Registration Number
- NCT00865891
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States
A Relative Bioavailability Study of Metformin HCl 500 mg ER Tablets Under Fasting Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: CLUCOPHAGE® XR 500 mg tablets, single dose
- First Posted Date
- 2009-03-19
- Last Posted Date
- 2010-08-17
- Lead Sponsor
- Actavis Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT00865748
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States
A Relative Bioavailability Study of Mirtazapine 15 mg Tablets Under Fasting Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-03-19
- Last Posted Date
- 2010-08-17
- Lead Sponsor
- Actavis Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT00865696
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States
A Limited Food Effect Study of Gabapentin 800 mg Tablets
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-03-19
- Last Posted Date
- 2010-08-17
- Lead Sponsor
- Actavis Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT00865631
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States
The Dose-response Study of Topically Delivered Halobetasol Propionate Ointment in Normal Skin in Healthy Adult Subjects
- First Posted Date
- 2009-03-19
- Last Posted Date
- 2010-08-17
- Lead Sponsor
- Actavis Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT00865267
- Locations
- 🇺🇸
DermTech International, San Diego, California, United States
A Relative Bioavailability Study of Metformin HCl 500 mg ER Tablets Under Fasting Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: CLUCOPHAGE® XR 500 mg tablets, single dose
- First Posted Date
- 2009-03-19
- Last Posted Date
- 2010-08-17
- Lead Sponsor
- Actavis Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT00865839
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States
Single Dose Two-Way Crossover Fasted Bioequivalence Study of Nabumetone 750 mg Tablets in Healthy Volunteers
- First Posted Date
- 2009-03-19
- Last Posted Date
- 2010-08-17
- Lead Sponsor
- Actavis Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT00864968
- Locations
- 🇺🇸
AAIPharma Inc., AAI Clinic, Morrisville, North Carolina, United States
A Relative Bioavailability Study of Metformin HCl 750 mg ER Tablets Under Fasting Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-03-19
- Last Posted Date
- 2010-08-17
- Lead Sponsor
- Actavis Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT00865072
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States
A Relative Bioavailability Study of Mirtazapine 15 mg Tablets Under Non-fasting Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-03-19
- Last Posted Date
- 2010-08-17
- Lead Sponsor
- Actavis Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT00865384
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States
A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Fasting Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: CLUCOVANCE® 5 mg/500 mg Tablets, single dose
- First Posted Date
- 2009-03-19
- Last Posted Date
- 2010-08-17
- Lead Sponsor
- Actavis Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT00865436
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States
© Copyright 2025. All Rights Reserved by MedPath